Advertisement

Endothelium Dependent Relaxation and Atherosclerosis

  • N. Sreeharan
  • R. Jayakody
  • M. Senaratne
  • A. Thomson
  • T. Kappagoda
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 67)

Abstract

In 1980, Furchgott & Zawadzki demonstrated that the endothelium of the rabbit aorta releases a factor(s) with vasodilator properties in response to acetylcholine (1). This discovery helped to explain two phenomena that had remained pharmacological “paradoxes” — (i) the potent contractile effect of acetylcholine on non-vascular smooth muscle and the concurrent vasodilator action in-vivo on most peripheral vascular beds and (ii) the inability of acetylcholine to relax isolated preparations of blood vessels in-vitro. Furchgott’s group showed that the lack of relaxation to acetylcholine in helical strips of rabbit aorta (which was the standard in-vitro preparation at the time) was the result of unintentional removal of the endothelium during mounting. It was found that with care taken to avoid damage to the intima, any in-vitro preparation (whether a helical strip, a ring or a transverse strip) always relaxed to acetylcholine. Conversely, intentional removal of the intima always resulted in the loss of the relaxatory response of the preparation to acetylcholine.

Keywords

Arachidonic Acid Donor Tissue Relaxatory Response Endothelium Dependent Relaxation Rabbit Aorta 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Furchgott, R.F. Circ. Res. 53: 557–573, 1983.PubMedCrossRefGoogle Scholar
  2. 2.
    Dey, J.G., Claeys, M. and Vanhoutte, P.M. J. Pharmacol. Exp. Ther. 222: 166–173, 1982.Google Scholar
  3. 3.
    Cocks, T.M. and Angus, J.A. Nature 305: 627–630, 1983.PubMedCrossRefGoogle Scholar
  4. 4.
    DeMey, J.G. and Vanhoutte, P.M. J. Physiol. (Lond), 316: 347–355, 1981.Google Scholar
  5. 5.
    Furchgott, R.F. Trends Pharmacol. Sci. 2: 173–176, 1981.CrossRefGoogle Scholar
  6. 6.
    Van de Vorrde, J. and Leusen, I. Arch. Int. Pharmacodyn Ther. 256(2): 329–330, 1982.Google Scholar
  7. 7.
    Chand, N. and Altura B. Science 213; 1376–1379, 1981.PubMedCrossRefGoogle Scholar
  8. 8.
    Zawadzki, J.V., Cherry P.D. and Furchgott, R.F. Pharmacologist 22: 271, 1980.Google Scholar
  9. 9.
    Singer, H.A. and Peach M.J. Hypertension 4(Suppl II): 19–25, 1982.PubMedGoogle Scholar
  10. 10.
    Katusic, Z.S., Shepherd, J.T. and Vanhoutte, P.M. Circ. Res. 55: 575–579, 1984.PubMedCrossRefGoogle Scholar
  11. 11.
    Singer, H.A. and Peach M.J. Hypertention 4(Suppl II), 19–25, 1982.Google Scholar
  12. 12.
    Davis, J.M. and Williams, K.I. Prostaglandins 27:195–202, 1984.Google Scholar
  13. 13.
    Brain S., Williams T., Tippins J., Morris H. and Maclntyre I. Nature 313:54–56, 1985.PubMedCrossRefGoogle Scholar
  14. 14.
    Forstermann, U. and Neufang, B. Am. J. Physiol. 249(Heart Circ. Physiol. 18):H14-H19, 1985.PubMedGoogle Scholar
  15. 15.
    Holtz, J., Forestermann, U., Pohl, U., Giesler, M. and Bassenge, E. J. Cardiovasc. Pharmacol. 6:1161–1169, 1984.PubMedGoogle Scholar
  16. 16.
    Holtz, J., Pohl, U., Kellner, C. and Busse, R. Pflügers Arch. 400:R9, 1984.Google Scholar
  17. 17.
    Cherry, P.D., Furchgott, R.F., Zawadzki, J.V. and Jothianandan, D. Proc. Natl. Acad. Sci. U.S.A. 79:2106–2110, 1982.PubMedCrossRefGoogle Scholar
  18. 18.
    Altura, B.M. and Chand, N. Br. J. Pharmacol. 74:10–11, 1981.PubMedCrossRefGoogle Scholar
  19. 19.
    Dey, J.G. and Vanhoutte, P.M. Circ. Res. 51:439–447, 1982.CrossRefGoogle Scholar
  20. 20.
    Rapoport, R.M. and Murad, F. Circ. Res. 52:352–357, 1983.PubMedCrossRefGoogle Scholar
  21. 21.
    Griffith, T.M., Edwards, D.H., Lewis, M.J., Newby, A.C. and Henderson, A.H. Nature 308:645–647, 1984.PubMedCrossRefGoogle Scholar
  22. 22.
    Rubanyi, G.M., Lorenz, R.R. and Vanhoutte, P.M. Am. J. Physiol 249:H95-H101, 1985.PubMedGoogle Scholar
  23. 23.
    Kappagoda, C.T., Thomson, A.B.R., Sreeharan, N., Jayakody, R.L., and Senaratne, M.P.J. Journal of Molecular and Cellular Cardiology 18(Suppl 3):38, 1986. (Abstract)CrossRefGoogle Scholar
  24. 24.
    Rubanyi, G.M. and Vanhoutte, P.M. Clin Res. 33:522A, 1985.Google Scholar
  25. 25.
    Feigen, L.P., Pretus, H. and Ensley, H. Blood Vessels. 23:67, 1986 (Abstract).Google Scholar
  26. 26.
    Long, C.J. and Stone, T.W. Blood Vessels, 22:205–208, 1985.PubMedGoogle Scholar
  27. 27.
    Rubanyi, G.M., Schwartz, A. and Vanhoutte, P.M. Fed. Proc.45(3): 426, 1986.Google Scholar
  28. 28.
    Deudis, F.Y. Medical Hypotheses, 17:363–374, 1985.CrossRefGoogle Scholar
  29. 29.
    Furchgott, R.F. and Zawadzki, J.V. Nature 288:373–376, 1980.PubMedCrossRefGoogle Scholar
  30. 30.
    Furchgott, R.F. and Cherry, P.D., Zawadzki, J.V., Jothianandan, D.J. Cardiovasc. Pharmacol. 6(Suppl 2):5336–5343.Google Scholar
  31. 31.
    Rapoport, R.M. and Murad, F. J. Cyclic Nucleotide Res. 9:281–296, 1983.Google Scholar
  32. 32.
    Spector, A.A., Hoak, J.C., Fry, G.L., Denning, G.M., Stoll, L.L. and Smith, J.B. J. Clin. Invest. 65:1003–1012, 1980.PubMedCrossRefGoogle Scholar
  33. 33.
    Spector, A.A., Kaduce, T.L., Hoak, J.C. and Fry, G.L. J. Clin. Invest. 68:1003–1011, 1981.CrossRefGoogle Scholar
  34. 34.
    Denning, G.M., Figard, P.H., Kaduce, T.L. and Spector, A.A. J. Lipid Res. 24:993–1001, 1983.PubMedGoogle Scholar
  35. 35.
    Moncada, S., Gryglewski, R. and Bunting, S. and Vane, J.R. Nature, 263:663–665, 1976.PubMedCrossRefGoogle Scholar
  36. 36.
    Rodman, N.F., Jagannathan, S.N., Jenkins, J.J. III, Rodman, J.A. and Allender, P.A. In: Scanning electron Microscopy III, SEM Inc., AMF O’Hare, 1979, p. 835–840.Google Scholar
  37. 37.
    Peng, S.K., Taylor, C.B., Hill, J.C. and Morin, R.J. Atherosclerosis, 54:121–133, 1985.PubMedCrossRefGoogle Scholar
  38. 38.
    Goode, T.B., Davies, P.F., Reidy, M.A. and Bowyer, D.E. Atherosclerosis, 27:235–251, 1977.PubMedCrossRefGoogle Scholar
  39. 39.
    Taylor, K., Glagov, S., Lamberti, J., Vesselinovitch, D. and Schaffner, T. In: Scanning electron Microscopy II, SEM Inc., AMF O’Hare, 1978, p. 449–457.Google Scholar
  40. 40.
    Wissler, R.W., Vesselinovitch, D., Davis, H.R., Lambert, P.H. and Bekermeier, M. In: Atherosclerosis (Ed. K.T. Lee) 454:9–22, 1985.Google Scholar
  41. 41.
    Martin, W., Villani, G.M., Jothianandan, D. and Furchgott, R.F. J. Pharm. & Exp. Therap. 232:708–716, 1985.Google Scholar
  42. 42.
    Duff, G.L., Millan, G.C. and Ritchie, A.C. Am. J. Pathol. 33(5):845–873, 1957.PubMedGoogle Scholar
  43. 43.
    Jayakody, R.L., Senaratne, M.P.J., Thomson, A.B.R. and Kappagoda, C.T. Can. J. Physiol. & Pharmacol. 63:1206–1209, 1985.CrossRefGoogle Scholar
  44. 44.
    Chappel, S.P., Griffith, T.M., Henderson, A.H. and Lewis, M.J. Br. J. Pharm.85: 266P, 1985.Google Scholar
  45. 45.
    Freiman, P.C., Mitchell, G.M., Gagnon, N.J., Armstrong, M.L., Heistad, D.D. and Harrison, D.G. Fed. Proc. 45:767, 1986 (abstract).Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1987

Authors and Affiliations

  • N. Sreeharan
    • 1
  • R. Jayakody
    • 1
  • M. Senaratne
    • 1
  • A. Thomson
    • 1
  • T. Kappagoda
    • 1
  1. 1.Department of MedicineUniversity of AlbertaEdmontonCanada

Personalised recommendations